FDA Warning Letter — Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy
The FDA took a Warning Letter action against Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on February 27, 2018 (Roselle, IL). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy
- Date
- February 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Roselle, IL (United States)